| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TC-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | 4°C | ||||
|
TC-0163-4 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | 4°C | ||||
|
TS-M053-4 |
HLA-A*02:01 HBV pol Tetramer-FLLSLGIHL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLSLGIHL | 575-583 | 4°C | ||||
|
TC-0102-2 |
HLA-A*02:01 Insulin B Tetramer-HLVEALYLV-APC |
|
|||
|
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HLVEALYLV | 4°C | |||||
|
TC-0112-1 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLPLTVAEV | 4°C | |||||
|
TC-0122-2 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTRILTI | 4°C | |||||
|
TC-0151-4 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | 4°C | ||||
|
TS-M043-4 |
HLA-A*02:01 HCV NS5B 2594-2602 Tetramer-ALYDVVSKL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYDVVSKL | 2594-2602 | 4°C | ||||
|
TS-M078-4 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLYDGMEHL | 4°C | |||||
|
TS-0016-2 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLLQETELV | 689-697 | 4°C | ||||
|
TC-0118-1 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CVNGVCWTV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| CVNGVCWTV | 4°C | |||||
|
TC-0121-4 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALPHIIDEV | 4°C | |||||
|
TC-0162-4 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-BV421 |
|
|||
|
Others | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLFGLGFAI | 265-273 | 4°C | ||||
|
TS-M088-4 |
HLA-A*02:01 MUC1 Tetramer-LLLLTVLTV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLLTVLTV | 12-20 | 4°C | ||||
|
TS-M039-1 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| CINGVCWTV | 1073-1081 | 4°C | ||||
|
TC-0114-2 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQVNSLQTV | 4°C | |||||
|
TC-0120-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTV | 4°C | |||||
|
TC-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AILALLPAL | 105-133 | 4°C | ||||
|
TC-0146-1 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLEMLWRL | 125-133 | 4°C | ||||
|
TS-M047-4 |
HLA-A*02:01 HPV16 E6 Tetramer-KLPQLCTEL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPQLCTEL | 18-26 | 4°C | ||||
|
TS-M082-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | 4°C | ||||
|
TC-0116-4 |
HLA-A*02:01 LCMV GPC 447-455 Tetramer-YLVSIFLHL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLVSIFLHL | 4°C | |||||
|
TC-0150-1 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | 4°C | ||||
|
TS-M122-4 |
HLA-A*02:01 VZV IE62 Tetramer-ALWALPHAA-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALWALPHAA | 593-601 | 4°C | ||||
|
TC-0107-1 |
HLA-A*02:01 IGRP Tetramer-LNIDLLWSV-PE |
|
|||
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LNIDLLWSV | 4°C | |||||
|
TC-0112-2 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLPLTVAEV | 4°C | |||||
|
TC-0135-2 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLADQLIHL | 101-109 | 4°C | ||||
|
TC-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | 4°C | ||||
|
TC-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | 4°C | ||||
|
TC-0118-2 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer CVNGVCWTV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| CVNGVCWTV | 4°C | |||||
|
TC-0169-4 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GVRGRVEEI | 4°C | |||||
|
TC-0110-2 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLLFLLFSL | 4°C | |||||
|
TS-M076-4 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLWGPRALV | 271-279 | 4°C | ||||
|
TC-0128-4 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | 4°C | ||||
|
TC-0122-4 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTRILTI | 4°C | |||||
|
TC-0113-4 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | |||||
|
TC-0164-4 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | 4°C | ||||
|
TC-0113-2 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | |||||
|
TC-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | 4°C | ||||
|
TC-0150-2 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | 4°C | ||||
|
TC-0152-1 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | 4°C | ||||
|
TS-M072-4 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | 4°C | ||||
|
TC-0131-2 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDKGTYTL | 276-284 | 4°C | ||||
|
TC-0161-4 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | 4°C | ||||
|
TC-8006-1 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-PE
|
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | 4°C | ||||
|
TC-8032-1 |
HLA-A*03:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE
|
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | ||||
|
TC-8031-1 |
HLA-A*03:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE
|
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | ||||
|
TC-8016-1 |
HLA-A*11:01 EGFR852-860 L858R Tetramer-KITDFGRAK-PE
|
|
|||
|
Others | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| KITDFGRAK | 852-860 | 4°C | ||||
|
TC-8006-2 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-APC
|
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | 4°C | ||||
|
TS-M250-1 |
HLA-A*02:01 EBV BRLF1 Tetramer-YVLDHLIVV-PE
|
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YVLDHLIVV | 109-117 | 4°C | ||||
|
TS-M243-1 |
HLA-A*02:01 UGCGL2 Neoepitope Tetramer-GLLDEDFYA-PE
|
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLDEDFYA | 4°C | |||||
|
TC-8026-2 |
HLA-A*24:02 NY-ESO-1158-166 Tetramer-LLMWITQCF-APC
|
|
|||
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| LLMWITQCF | 158-166 | 4°C | ||||
|
TS-M251-1 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-PE
|
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KIFSEVTLK | 4°C | |||||
|
TC-8025-1 |
HLA-A*11:01 HPV16 E789-97 Tetramer-IVCPICSQK-PE
|
|
|||
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| IVCPICSQK | 89-97 | 4°C | ||||
|
TS-M271-1 |
HLA-B*07:02 GNB5 Neoepitope Tetramer-RVSTLRVSL-PE
|
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| RVSTLRVSL | 4°C | |||||
|
TS-M252-1 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-PE
|
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KILDAVVAQK | 4°C | |||||
|
TC-8029-1 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-PE
|
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | 4°C | ||||
|
TC-8001-1 |
HLA-A*11:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE
|
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | ||||
|
TS-M271-2 |
HLA-B*07:02 GNB5 Neoepitope Tetramer-RVSTLRVSL-APC
|
|
|||
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| RVSTLRVSL | 4°C | |||||
|
TS-M255-1 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-PE
|
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLYEEPLLK | 4°C | |||||
|
TS-M248-1 |
HLA-A*02:01 Insulin Tetramer-ALWGPDPAAA-PE
|
|
|||
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALWGPDPAAA | 15-24 | 4°C | ||||
|
TS-M246-1 |
HLA-A*02:01 GOLGA3 Neoepitope Tetramer-SLDLTTSPV-PE
|
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLDLTTSPV | 4°C | |||||
|
TC-8023-2 |
HLA-A*11:01 KRAS7-16 G12S Tetramer- VVVGASGVGK-APC
|
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGASGVGK | 7-16 | 4°C | ||||
|
TS-M274-2 |
HLA-B*07:02 Filamin A Neoepitope Tetramer-CVRVSGQGL-APC
|
|
|||
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| CVRVSGQGL | 4°C | |||||
|
TS-M255-2 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-APC
|
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLYEEPLLK | 4°C | |||||
|
TS-M201-2 |
HLA-A*01:01 TRIP12 Neoepitope Tetramer-PSDTRQMLFY-APC
|
|
|||
|
cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| PSDTRQMLFY | 4°C | |||||
|
TS-M272-1 |
HLA-B*07:02 MLL3 Neoepitope Tetramer-KPSDTPRPVM-PE
|
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPSDTPRPVM | 4°C | |||||
|
TS-M269-1 |
HLA-B*07:02 UBR4 Neoepitope Tetramer-RPHVPESAF-PE
|
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| RPHVPESAF | 4°C | |||||
|
TS-M257-1 |
HLA-A*11:01 HBcAg Tetramer-STLPETTVVRR-PE
|
|
|||
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| STLPETTVVRR | 141-151 | 4°C | ||||
|
TS-M230-1 |
HLA-A*02:01 USP28 Neoepitope Tetramer-LIIPFIHLI-PE
|
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LIIPFIHLI | 4°C | |||||
|
TS-M202-1 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-PE
|
|
|||
|
cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
|
| ILDTAGREEY | 4°C | |||||
|
TC-8033-2 |
HLA-A*03:01 KRAS8-16 WT Tetramer-VVGAGGVGK-APC
|
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | 4°C | ||||
|
TC-8031-2 |
HLA-A*03:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-APC
|
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | ||||
|
TC-8030-2 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-APC
|
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | ||||
|
TC-8022-1 |
HLA-A*11:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE
|
|
|||
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | ||||
|
TC-8010-1 |
HLA-A*02:01 KRAS5-14 G12D Tetramer-KLVVVGADGV-PE
|
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGADGV | 5-14 | 4°C | ||||
|
TC-8002-2 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-APC
|
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | 4°C | ||||
|
TS-M251-2 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-APC
|
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KIFSEVTLK | 4°C | |||||
|
TS-M275-1 |
HLA-B*07:02 MYADM Neoepitope Tetramer-SPMIVGSPW-PE
|
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| SPMIVGSPW | 4°C | |||||
|
TS-M274-1 |
HLA-B*07:02 Filamin A Neoepitope Tetramer-CVRVSGQGL-PE
|
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| CVRVSGQGL | 4°C | |||||
|
TS-M256-1 |
HLA-A*11:01 Dengue virus NS3 Tetramer-GTSGSPIIDK-PE
|
|
|||
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| GTSGSPIIDK | 133-142 | 4°C | ||||
|
TS-M242-1 |
HLA-A*02:01 MCT2 Neoepitope Tetramer-AMAGSLVFL-PE
|
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| AMAGSLVFL | 4°C | |||||
|
TS-M235-1 |
HLA-A*02:01 Filamin-A Neoepitope Tetramer-HIAKSLFEV-PE
|
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HIAKSLFEV | 4°C | |||||
|
TC-8034-2 |
HLA-A*03:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-APC
|
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | 4°C | ||||
|
TC-8034-1 |
HLA-A*03:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-PE
|
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | 4°C | ||||
|
TC-8032-2 |
HLA-A*03:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-APC
|
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | ||||
|
TC-8030-1 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE
|
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | ||||
|
TC-8026-1 |
HLA-A*24:02 NY-ESO-1158-166 Tetramer-LLMWITQCF-PE
|
|
|||
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| LLMWITQCF | 158-166 | 4°C | ||||
|
TC-8017-1 |
HLA-A*02:01 AFP158-166 Tetramer-FMNKFIYEI-PE
|
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMNKFIYEI | 158-166 | 4°C | ||||
|
TC-8012-2 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-APC
|
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | 4°C | ||||
|
TC-8005-2 |
HLA-A*11:01 KRAS8-16 WT Tetramer-VVGAGGVGK-APC
|
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | 4°C | ||||
|
TS-M264-2 |
HLA-A*11:01 EBV BRLF1 Tetramer-ATIGTAMYK-APC
|
|
|||
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| ATIGTAMYK | 134-142 | 4°C | ||||
|
TS-M250-2 |
HLA-A*02:01 EBV BRLF1 Tetramer-YVLDHLIVV-APC
|
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YVLDHLIVV | 109-117 | 4°C | ||||
|
TS-M202-2 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-APC
|
|
|||
|
cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| ILDTAGREEY | 4°C | |||||
|
TS-M276-1 |
HLA-B*07:02 DOPEY2 Neoepitope Tetramer-KPFCVLISL-PE
|
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPFCVLISL | 4°C | |||||
|
TS-M254-1 |
HLA-A*03:01 MYO1B Neoepitope Tetramer-KINKNPKYK-PE
|
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KINKNPKYK | 4°C | |||||
|
TS-M244-1 |
HLA-A*02:01 FNDC3B Neoepitope Tetramer-VVMSWAPPV-PE
|
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVMSWAPPV | 4°C | |||||
|
TS-M203-1 |
HLA-A*02:01 HPV16 E7 Tetramer-LLMGTLGIV-PE
|
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLMGTLGIV | 82-90 | 4°C | ||||
|
TS-M201-1 |
HLA-A*01:01 TRIP12 Neoepitope Tetramer-PSDTRQMLFY-PE
|
|
|||
|
cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
|
| PSDTRQMLFY | 4°C | |||||
|
TC-8033-1 |
HLA-A*03:01 KRAS8-16 WT Tetramer-VVGAGGVGK-PE
|
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | 4°C | ||||